top
Search terms
Results 1 - 10 of 17 - ordered by :
Pages: 1 2
Escardio

Sweden is unique among countries in having comprehensive and high-quality cardiovascular registry data, says Prof. Omerovic, allowing a relatively large number of patients to be investigated over a ...

Date : 28/05/2019
Escardio

In the Hokusai VTE Cancer[1], cancer patients with (n=1050) were randomly assigned to either LMWH (at least 5 days) followed by the DOAC edoxaban (60 mg o.i.d.) or subcutaneous daltaparin (200 IU per ...

Date : 30/11/2018
Escardio

The Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT) already published and presented during AHA 20181 randomized 8179 patients with established ...

Date : 06/05/2019
Escardio

AUGUSTUS was a prospective, multicenter, two-by-two factorial, randomized clinical trial, supported by the pharmaceutic industry, including 4614 patients with atrial fibrillation who had a recent ...

Date : 06/05/2019
Escardio

In 2016 the CROS study has shown that even in the era of statin use and acute revascularisation, multidisciplinary cardiovascular (CV) rehabilitation leads to significant reductions in morbidity and ...

Date : 18/01/2019
Escardio

Over a median follow-up of 18.2 months, the primary outcome occurred in 386 of 2,373 patients (16.3%) in the dapagliflozin group and in 502 of 2,371 patients (21.2%) in the placebo group (hazard ...

Date : 01/09/2019
Escardio

Up to 50% of patients with ST-segment elevation myocardial infarction (STEMI) have multivessel coronary artery disease. Prior randomised trials found declines in composite outcomes with non-culprit ...

Date : 01/09/2019
Escardio

The findings were clear, but unexpected. “Since plaque erosion or rupture, thromboembolism, spontaneous coronary dissection and microvascular disorders are commonly encountered in MINOCA ...

Date : 01/09/2019
Escardio

Professor Deepak L. Bhatt (Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA) describes the rationale for the study, which is the largest trial in type 2 ...

Date : 02/09/2019
Escardio

(7) The study therefore used an innovative social marketing campaign to introduce a new product called Salt-Liz, a name chosen and approved by locals. Among the 1,865 participants (79%) without ...

Date : 02/09/2019